Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report-Reference-Cited by-同舟云学术

Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report

Published:2024-06-28 Issue:3 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Li Yun¹,Xu Yali²,Cai Shifeng³,Li Jingwen⁴,Ruan Fangying⁵,Xia Chaoran⁵,Luo Peng⁵,Li Jun⁶

Affiliation:

1. Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China

2. Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China

3. Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China

4. Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China

5. Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., Shanghai 201321, P.R. China

6. Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China

Publisher

Spandidos Publications

Reference27 articles.

1. Epidemiology of lung cancer;Thandra;Contemp Oncol (Pozn),2021

2. Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis;Schad;PLoS One,2018

3. Results of radiation therapy as local ablative therapy for oligometastatic non-small cell lung cancer;Billing;Cancers (Basel),2021

4. A lung adenocarcinoma patient with a rare EGFR E709_T710delinsD mutation showed a good response to afatinib treatment: A case report and literature review;Wei;Front Oncol,2021

5. Concomitant mutations in EGFR 19Del/L858R mutation and their association with response to EGFR-TKIs in NSCLC patients;Liang;Cancer Manag Res,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erlotinib;Reactions Weekly;2024-09-07